Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: Involvement of neuropeptide y

British Journal of Pharmacology

Volumn 164, Issue 2 B, 2011, Pages 704-718

  Taksande, B G ^a   Kotagale, N R ^a   Nakhate, K T ^b   Mali, P D ^a   Kokare, D M ^b   Hirani, K ^c   Subhedar, N K ^d   Chopde, C T ^a   Ugale, R R ^a  

^a New Kamptee   (India)

^b RTM NAGPUR UNIVERSITY   (India)

^c UNIVERSITY OF MIAMI   (United States)

^d INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH   (India)

Author keywords

2 adrenoceptors; agmatine; food intake; neuropeptide Y; paraventricular nucleus of hypothalamus

Indexed keywords

AGMATINE; APPETITE STIMULANT; CLONIDINE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; YOHIMBINE;

ANIMAL EXPERIMENT; APPETITE; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENTIATION; DRUG RECEPTOR BINDING; FEEDING BEHAVIOR; FEEDING DISORDER; FOOD INTAKE; HYPERPHAGIA; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; IMMUNOREACTIVITY; LATERAL HYPOTHALAMUS; MALE; NERVE CELL STIMULATION; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; AGMATINE; ANIMALS; ARCUATE NUCLEUS; ARGININE; CLONIDINE; DRUG SYNERGISM; EATING; FEEDING BEHAVIOR; HYPERPHAGIA; MALE; NEUROPEPTIDE Y; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, NEUROPEPTIDE Y; YOHIMBINE;

EID: 80052243546     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01484.x     Document Type: Article

References (91)

1. Allen LG, Crowley WR, Kalra SP, (1987). Interactions between neuropeptide Y and adrenergic systems in the stimulation of luteinizing hormone release in steroid-primed ovariectomized rats. Endocrinology 121: 1953-1959. (Pubitemid 18016964)
2. Armstrong S, (1980). A chronometric approach to the study of feeding behavior. Neurosci Biobehav Rev 4: 27-53. (Pubitemid 10050860)
3. Auguet M, Viossat I, Marin JG, Chabrier PE, (1995). Selective inhibition of inducible nitric oxide synthase by agmatine. Jpn J Pharmacol 69: 285-287.
4. Banihashemi L, Rinaman L, (2006). Noradrenergic inputs to the bed nucleus of the stria terminalis and paraventricular nucleus of the hypothalamus underlie hypothalamic-pituitary-adrenal axis but not hypophagic or conditioned avoidance responses to systemic yohimbine. J Neurosci 26: 11442-11453. (Pubitemid 44772175)
5. Beck B, (2006). Neuropeptide Y in normal eating and in genetic and dietary-induced obesity. Phi Trans R Soc B 361: 1159-1185. (Pubitemid 44874227)
6. Bence AK, Worthen DR, Stables JP, Crooks PA, (2003). An in vivo evaluation of the antiseizure activity and acute neurotoxicity of agmatine. Behav Brain Res 74: 771-775. (Pubitemid 36126556)
7. Bhisikar SM, Kokare DM, Nakhate KT, Chopde CT, Subhedar NK, (2009). Tolerance to ethanol sedation and withdrawal hyper-excitability is mediated via neuropeptide Y Y1 and Y5 receptors. Life Sci 85: 765-772.
8. Boudaba C, Di S, Tasker JG, (2003). Presynaptic noradrenergic regulation of glutamate inputs to hypothalamic magnocellular neurones. J Neuroendocrinol 15: 803-810. (Pubitemid 36874377)
9. Clark JT, Gist RS, Kalra SP, (1988). Alpha2-adrenoceptor blocked attenuated behavior induced by neuropeptide Y and epinephrine. Physiol Behav 43: 417-422.
10. Crowley WR, Kalra SP, (1987). Neuropeptide Y stimulates the release of luteinizing hormone-releasing hormone from medial basal hypothalamus in vitro: modulation by ovarian hormones. Neuroendocrinology 46: 97-103. (Pubitemid 17106405)
11. Currie PJ, Wilson LM, (1992). Yohimbine attenuates clonidine-induced feeding and macronutrient selection in genetically obese (ob/ob) mice. Pharmacol Biochem Behav 43: 1039-1046.
12. Currie PJ, Coscina DV, Bishop C, Coiro CD, Koob GF, Rivier J, et al,. (2001). Hypothalamic paraventricular nucleus injections of urocortin alter food intake and respiratory quotient. Brain Res 916: 222-228. (Pubitemid 32971923)
13. Dandekar MP, Nakhate KT, Kokare DM, Subhedar NK, (2011). Effect of nicotine on feeding and body weight in rats: involvement of cocaine-and amphetamine-regulated transcript peptide. Behav Brain Res 219: 31-38.
14. Deo GS, Dandekar MP, Upadhya MA, Kokare DM, Subhedar NK, (2010). Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: behavioral and immunocytochemical evidences. Brain Res 1318: 77-86.
15. Dourish CT, Hutson PH, Curzon G, (1985). Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology (Berl) 86: 197-204. (Pubitemid 15077754)
16. Dube MG, Sahu A, Kalra PS, Kalra SP, (1992). Neuropeptide Y release is elevated from the microdissected paraventricular nucleus of food-deprived rats: an in vitro study. Endocrinology 131: 684-688.
17. Ebenezer IS, (1992). Effects of the 5HT1A agonist, 8-OH-DPAT, on operant food intake in nondeprived rats. Neuroreport 3: 1019-1022.
18. Everitt BJ, Hokfelt T, Terenius L, Tatemoto K, Mutt V, Goldstein M, (1984). Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience 11: 443-462. (Pubitemid 14155718)
19. Fletcher PJ, Davies M, (1990). The involvement of 5-hydroxytryptaminergic and dopaminergic mechanisms in the eating induced by buspirone, gepirone and ipsapirone. Br J Pharmacol 99: 519-525. (Pubitemid 20069156)
20. Fletcher PJ, Rizos Z, Sinyard J, Tampakeras M, Higgins GA, (2008). The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues. Neuropsychopharmacology 33: 1402-1412. (Pubitemid 351521717)
21. Franco-Cereceda A, Nagata M, Svensson TH, Lundberg JM, (1987). Differential effects of clonidine and reserpine treatment on neuropeptide Y content in some sympathetically innervated tissues of the guinea-pig. Eur J Pharmacol 142: 267-273. (Pubitemid 18045251)
22. Gilbert F, Dourish CT, (1987). Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT. Psychopharmacology (Berl) 93: 349-352. (Pubitemid 17160659)
23. Goldman CK, Marino L, Leibowitz SF, (1985). Postsynaptic alpha 2-noradrenergic receptors mediate feeding induced by paraventricular nucleus injections of norepinephrine and clonidine. Eur J Pharmacol 115: 11-19. (Pubitemid 16233354)
24. Gonzalez C, Regunathan S, Reis DJ, Estrada C, (1996). Agmatine is an endogenous modulator of noradrenergic neurotransmission in the rat tail artery. Br J Pharmacol 119: 677-684. (Pubitemid 26356580)
25. Gorbatyuk OS, Milner TA, Wang G, Regunathan S, Reis DJ, (2001). Localization of agmatine in vasopressin and oxytocin neurons of the rat hypothalamic paraventricular and supraoptic nuclei. Exp Neurol 171: 235-245. (Pubitemid 32955285)
26. Goyal SN, Kokare DM, Chopde CT, Subhedar NK, (2006). Alpha-melanocyte stimulating hormone antagonizes antidepressant-like effect of neuropeptide Y in Porsolt's test in rats. Pharmacol Biochem Behav 85: 369-377. (Pubitemid 44889261)
27. Halaris A, Plietz J, (2007). Agmatine: metabolic pathway and spectrum of activity in brain. CNS Drugs 21: 885-900. (Pubitemid 47557104)
28. Harfstrand A, Fuxe K, Terenius L, Kalia M, (1987). Neuropeptide Y immunoreactive perikarya and nerve terminals in the rat medulla oblongata: relationship to cytoarchitecture and catecholamine cell groups. J Comp Neurol 260: 20-35. (Pubitemid 17081444)
29. Heilig M, Wahlestedt C, Widerlöv E, (1988). Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with α-adrenoceptors. Eur J Pharmacol 157: 205-213.
30. Huguet F, Comoy E, Piriou A, Bohuon C, (1993). Age-related changes of noradrenergic-NPY interaction in rat brain: norepinephrine, NPY levels and alpha-adrenoceptors. Brain Res 625: 256-260. (Pubitemid 23300421)
31. Isome M, Lortie MJ, Murakami Y, Parisi E, Matsufuji S, Satriano J, (2007). The antiproliferative effects of agmatine correlate with the rate of cellular proliferation. Am J Physiol Cell Physiol 293: C705-C711. (Pubitemid 47235194)
32. Jhanwar-Uniyal M, Leibowitz SF, (1986). Impact of food deprivation on alpha 1- and alpha 2-noradrenergic receptors in the paraventricular nucleus and other hypothalamic areas. Brain Res Bull 17: 889-896. (Pubitemid 17215237)
33. 2-noradrenergic receptors in the paraventricular nucleus and other brain areas: relation to circulating corticosterone and feeding behavior. Life Sci 38: 473-482. (Pubitemid 16163429)
34. Jhanwar-Uniyal M, Beck B, Burlet C, Leibowitz SF, (1990). Diurnal rhythm of neuropeptide Y like immunoreactivity in the suprachiasmatic, arcuate and paraventricular nuclei and other hypothalamic sites. Brain Res 536: 331-334.
35. Jhanwar-Uniyal M, Awad IR, Gearhart GM, Finkelstein JA, Leibowitz SF, (1991). Higher alpha-noradrenergic receptors in paraventricular nucleus of obese Zucker rats: decline after food deprivation. Pharmacol Biochem Behav 40: 853-859.
36. Kalra SP, Dube MG, Sahu A, Phelps CP, Kalra PS, (1991). Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA 88: 10931-10935. (Pubitemid 21915953)
37. Kalra SP, Pearson E, Sahu A, Kalra PS, (1995). Agmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing hormone release in vitro. Neurosci Lett 194: 165-168.
38. Kalra PS, Dube MG, Xu B, Farmerie WG, Kalra SP, (1998). Evidence that dark-phase hyperphagia induced by neurotoxin 6-hydroxydopamine may be due to decreased leptin and increased neuropeptide Y signaling. Physiol Behav 63: 829.
39. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS, (1999). Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20: 68-100. (Pubitemid 29092036)
40. Kamdi SP, Nakhate KT, Dandekar MP, Kokare DM, Subhedar NK, (2009). Participation of corticotropin-releasing factor type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats. Appetite 53: 354-362.
41. Kanatani A, Ishihara A, Iwaasa H, Nakamura K, Okamoto O, Hidaka M, (2000). L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist. Biochem Biophys Res Commun 272: 169-173. (Pubitemid 30444917)
42. Kask A, Rago L, Harro J, (1998). Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226. Br J Pharmacol 124: 1507-1515. (Pubitemid 28360575)
43. Kimura T, Maji T, Ashida K, (1970). Periodicity of food intake and lipogenesis in rats subjected to two different feeding plans. J Nutr 100: 691-697.
44. Kokare DM, Patole AM, Carta A, Chopde CT, Subhedar NK, (2006). GABA(A) receptors mediate orexin-A induced stimulation of food intake. Neuropharmacology 50: 16-24. (Pubitemid 43069768)
45. Konturek PC, Konturek JW, Czesnikiewicz-Guzik M, Brzozowski T, Sito E, Konturek SJ, (2005). Neuro-hormonal control of food intake: basic mechanisms and clinical implications. J Physiol Pharmacol 56: 5-25. (Pubitemid 43120939)
46. 2-adrenoceptors. Behav Brain Res 213: 161-174.
47. Krauchi K, Wirz-Justice A, Morimasa T, Willener R, Feer H, (1984). Hypothalamic alpha 2- and beta-adrenoceptor rhythms are correlated with circadian feeding: evidence from chronic methamphetamine treatment and withdrawal. Brain Res 32: 83-90. (Pubitemid 15176897)
48. Lambert PD, Couceyro PR, McGirr KM, Dall Vechia SE, Smith Y, Kuhar MJ, (1998). CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse 29: 293-298. (Pubitemid 28328673)
49. Lavinsky D, Arteni NS, Netto CA, (2003). Agmatine induces anxiolysis in the elevated plus maze task in adult rats. Behav Brain Res 141: 19-24. (Pubitemid 36382913)
50. Le A, Funk D, Harding S, Juzytsch W, Fletcher PJ, (2009). The role of noradrenaline and 5-hydroxytryptamine in yohimbine-induced increases in alcohol-seeking in rats. Psychopharmacology 204: 477-488.
51. Leibowitz SF, Brown O, Tretter JR, Kirschgessner A, (1985). Norepinephrine, clonidine, and tricyclic antidepressants selectively stimulate carbohydrate ingestion through noradrenergic system in the paraventricular nucleus. Pharmacol Biochem Behav 23: 541-550. (Pubitemid 16191747)
52. Levin BE, Israel P, Lattemann DP, (1998). Insulin selectively downregulates alpha-2-adrenoceptors in the arcuate and dorsomedial nucleus. Brain Res Bull 45: 179-181. (Pubitemid 28027801)
53. Li DP, Atnip LM, Chen SR, Pan HL, (2005). Regulation of synaptic inputs to paraventricular-spinal output neurons by alpha2 adrenergic receptors. J Neurophysiol 93: 393-402. (Pubitemid 40626848)
54. Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ, (1994). Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263: 966-969. (Pubitemid 24094560)
55. Li SJ, Scanlon MN, Járai Z, Varga K, Gantenberg NS, Lazar-Wesley E, et al,. (1996). Alpha-2-Adrenergic activation of proopiomelanocortin- containing neurons in the arcuate nucleus causes opioid-mediated hypotension and bradycardia. Neuroendocrinology 63: 275-283. (Pubitemid 26070813)
56. Liu P, Bergin DH, (2009). Differential effects of i.c.v. microinfusion of agmatine on spatial working and reference memory in the rat. Neuroscience 159: 951-961.
57. McKibbin PE, Rogers P, Williams G, (1991). Increased neuropeptide Y concentrations in the lateral hypothalamic area of the rat after the onset of darkness: possible relevance to the circadian periodicity of feeding behavior. Life Sci 48: 2527-2533.
58. Mansur SS, Terenzi MG, Neto JM, Faria MS, Paschoalini MA, (2010). Changes in food intake and anxiety-like behaviors after clonidine injected into the median raphe nucleus. Behav Brain Res 212: 71-77.
59. Matthews JW, Booth DA, Stolerman IP, (1986). Intrahypothalamic noradrenaline injection in the rat enhances operant licking but not lever pressing for milk reward. Appetite 7: 355-364. (Pubitemid 17217668)
60. A receptors in nucleus accumbens shell mediate the hyperphagia and weight gain following haloperidol treatment in rats. Life Sci 84: 156-163.
61. Molderings GJ, Gothert M, (1995). Inhibitory presynaptic imidazoline receptors on sympathetic nerves of rabbit aorta differ from I1 and I2 imidazoline binding sites. Naunyn Schmiedebergs Arch Pharmacol 351: 507-516.
62. Morgan DG, Small CJ, Abusnana S, Turton M, Gunn I, Heath M, (1998). The NPY Y1 receptor antagonist BIBP 3226 blocks NPY induced feeding via a non-specific mechanism. Regul Pept 75-76: 377-382. (Pubitemid 28477550)
63. Morien A, Cassone VM, Wellman PJ, (1999). Diurnal changes in paraventricular hypothalamic alpha1 and alpha2-adrenoceptors and food intake in rats. Pharmacol Biochem Behav 63: 33-38. (Pubitemid 29206559)
64. Nagata M, Franco-Cereceda A, Svensson TH, Lundberg JM, (1986). Clonidine treatment elevates content of neuropeptide Y in cardiac nerves. Acta Physiol Scand 128: 321-322. (Pubitemid 16032366)
65. Nakhate KT, Dandekar MP, Kokare DM, Subhedar NK, (2009). Involvement of neuropeptide Y Y1 receptors in the acute, chronic and withdrawal effects of nicotine on feeding and body weight in rats. Eur J Pharmacol 609: 78-87.
66. Nakhate KT, Kokare DM, Singru PS, Taksande AG, Kotwal SD, Subhedar NK, (2010). Hypothalamic cocaine- and amphetamine-regulated transcript peptide is reduced and fails to modulate feeding behavior in rats with chemically-induced mammary carcinogenesis. Pharmacol Biochem Behav 97: 340-349.
67. Nakhate KT, Kokare DM, Singru PS, Subhedar NK, (2011). Central regulation of feeding behavior during social isolation of rat: evidence for the role of endogenous CART system. Int J Obes (Lond) 35: 773-784.
68. Olmos G, DeGregorio-Rocasolano N, Paz Regalado M, Gasull T, Assumpcio Boronat M, Trullas R, (1999). Protection by imidazoline drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br J Pharmacol 127: 1317-1326. (Pubitemid 29358932)
69. Onal A, Delen Y, Ulker S, Soykan N, (2004). Agmatine attenuates neuropathic pain in rats: possible mediation of nitric oxide and noradrenergic activity in the brainstem and cerebellum. Life Sci 73: 413-428. (Pubitemid 36577566)
70. Otake K, Ruggiero DA, Regunathan S, Wang H, Milner TA, Reis DJ, (1998). Regional localization of agmatine in the rat brain: an immunocytochemical study. Brain Res 787: 1-14. (Pubitemid 28279794)
71. Paxinos G, Watson C, (1998). The Rat Brain in Stereotaxic Coordinates. Academic Press: London.
72. Pedrazzini T, Pralong F, Grouzmann E, (2003). Neuropeptide Y: the universal soldier. Cell Mol Life Sci 60: 350-377. (Pubitemid 36343914)
73. Peinado JM, Myers RD, (1987). Norepinephrine release from PVN and lateral hypothalamus during perfusion with 2-DG or insulin in the sated and fasted rat. Pharmacol Biochem Behav 27: 715-721. (Pubitemid 17132287)
74. Prasad A, Prasad C, (1996). Agmatine enhances caloric intake and dietary carbohydrate preference in satiated rats. Physiol Behav 60: 1187-1189. (Pubitemid 26336741)
75. Raasch W, Regunathan S, Li G, Reis DJ, (1995). Agmatine, the bacterial amine, is widely distributed in mammalian tissues. Life Sci 56: 2319-2330.
76. Reis DJ, Regunathan S, (2000). Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci 21: 187-193. (Pubitemid 30243201)
77. Satoh N, Ogawa Y, Katsuura G, Hayase M, Tsuji T, Imagawa K, et al,. (1997). The arcuate nucleus as a primary site of satiety effect of leptin in rats. Neurosci Lett 224: 149-152. (Pubitemid 27140403)
78. Sawchenko PE, Swanson LW, Grazanna R, Howe PRC, Bloom SR, Polak JM, (1985). Colocaiization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 241: 138-153. (Pubitemid 16202808)
79. Scopinho AA, Guimaraes FS, Correa FM, Resstel LB, (2011). Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists. Pharmacol Biochem Behav 98: 268-272.
80. Sener A, Lebrun P, Blachier F, Malaisse WJ, (1989). Stimulus-secretion coupling of arginine-induced insulin release: insulinotropic action of agmatine. Biochem Pharmacol 38: 327-330. (Pubitemid 19033344)
81. Smiałowska M, Obuchowicz E, Turchan J, Herman ZS, Przewłocki R, (1997). Clonidine administration increases neuropeptide Y immunoreactivity and neuropeptide Y mRNA in the rat cerebral cortex neurons. Neuropeptides 31: 203-207. (Pubitemid 27297772)
82. Stanley BG, Leibowitz SF, (1985). Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior. Proc Natl Acad Sci USA 82: 3940-3943. (Pubitemid 15246469)
83. Stanley BG, Schwartz DH, Hernandez L, Hoebei BG, Leibowitz SF, (1989). Patterns of extracellular norepinephrine in the paraventricular hypothalamus: relationship to circadian rhythm and deprivation-induced eating behavior. Life Sci 45: 275-282. (Pubitemid 19196595)
84. Taksande BG, Kotagale NR, Tripathi SJ, Ugale RR, Chopde CT, (2009). Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine. Neuropharmacology 57: 415-424.
85. Taksande BG, Kotagale NR, Patel MR, Shelkar GP, Ugale RR, Chopde CT, (2010). Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats. Eur J Pharmacol 637: 89-101.
86. Turnbull AV, Ellershaw L, Masters DJ, Birtles S, Boyer S, Carroll D, (2002). Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats. Diabetes 51: 2441-2449. (Pubitemid 34827392)
87. 1- and α2-adrenoceptors. Life Sci 53: 669-680.
88. Winter JC, Rabin RA, (1992). Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination. J Pharmacol Exp Ther 263: 682-689.
89. Yang XC, Reis DJ, (1999). Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J Pharmacol Exp Ther 288: 544-549. (Pubitemid 29119663)
90. Zomkowski AD, Hammes L, Lin J, Calixto JB, Santos ARS, Rodrigues ALS, (2002). Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport 13: 387-391. (Pubitemid 34293175)
91. Zomkowski AD, Rosaa OA, Lina J, (2004). Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test. Brain Res 1023: 253-263.